Ola Grahn, Partner/Member of the Swedish Bar Association

Profile

Ola Grahn co-heads the equity capital markets team at Setterwalls. Exceeding 20 years of professional expertise within equity capital markets, corporate and M&A, Ola is highly experienced and brings a strong strategic mindset of legal as well as commercial value to clients’ businesses.

Ola assists clients with equity capital markets and company law advice in connection with IPOs, public takeovers, new issues and incentive schemes. He also regularly advises listed companies in relation to corporate governance issues and is frequently engaged as chairman at general meetings. Further, Ola has vast experience from venture capital transactions assisting both venture capital firms and entrepreneurs in connection with fundraising and exits.

Språk: English, Swedish, Swedish

Karriär

2003-

Setterwalls

2002

Advokatfirman Hammarskiöld & Co, Stockholm

2002

Lund University, LL.M.

2002

Lund University, B.Sc.

Rekommendationer

“I believe that Ola Grahn has deep insight into the rules for publicly listed companies, our sector, and the various aspects coming up in relation to financing, insider information, and remuneration. He also has significant experience with cross-border listing.”

Legal 500
“Ola is an excellent, highly experienced and skilled lawyer within capital markets and corporate law.”

Chambers & Partners
“Ola Grahn is strategic, thoughtful, and incredibly knowledgeable across the full spectrum of legal and commercial issues.”

Chambers & Partners
“Ola Grahn is highly experienced, and delivered very strong and speedy support for us.”

Legal 500
“The lead partner Ola Grahn can grasp many different angles/disciplines and not solely related to capital markets. That provides us with a good foundation for making robust decisions and the potential consequences of these decisions.”

Legal 500
“Ola Grahn stands out for the ability to see beyond the strict legal aspects to have a solid understanding of our business.”

Legal 500
“Ola Grahn exhibits valuable insights into explaining and understanding the long-term consequences of legal decisions.”

Legal 500
“Always available. He has a great understanding of how a multinational high-growth startup operates.”

IFLR1000
“Highly experienced, good communications skills, pragmatic, and has broad competence.”

IFLR1000

Case

Setterwalls advises Cantargia in connection with a capital raise of approximately SEK 124 million and entering into a loan agreement

Setterwalls has advised Ascelia Pharma in connection with a private placement

Setterwalls has advised Iconovo in connection with a directed share issue and a rights issue

Setterwalls has advised the majority shareholders of Kaisa Technologies in connection with its divestment to Monterro

Setterwalls has advised Intellego Technologies in connection with SEK 210 million private placement

Setterwalls advises Alligator Bioscience in connection with a capital raise of approximately SEK 120 million and renegotiation of loan

Setterwalls advises Immunovia in connection with a rights issue of approximately SEK 100 million

Setterwalls has advised MH Sjukvårdsrådgivning Holding AB in the public takeover offer for MedHelp Care Aktiebolag AB (publ)

Setterwalls has advised Hortus Group in connection with the acquisition of TK-Pac

Setterwalls has advised Iconovo in connection with an oversubscribed rights issue of shares

Setterwalls advises Guard Therapeutics AB in connection with a rights issue

Setterwalls advises Nordic Waterproofing in connection with recommended public takeover bid from Kingspan

Setterwalls has advised Sound Bioventures, Novo Holdings och Pueros Bioventures in connection with investment in AnaCardio

Setterwalls advises Alligator Bioscience in connection with a rights issue of approximately SEK 280 million

Setterwalls advises BiBBInstruments in connection with a rights issue

Setterwalls has advised OptiCept Technologies in connection with a rights issue

Setterwalls advises Crunchfish in connection with a rights issue

Setterwalls advised Ascelia Pharma in connection with a fully subscribed rights issue of units

Setterwalls advised Immunovia in connection with a rights issue of units

Setterwalls advised Guard Therapeutics in connection with a private placement and subsequent rights issue of approximately SEK 140 million

Setterwalls has advised EQL Pharma in connection with listing on Nasdaq Stockholm

Setterwalls advises Resurs Holding in connection with a public takeover bid

Setterwalls advises BrainCool in connection with a rights issue

Setterwalls advises Alligator Bioscience in connection with rights issue of approximately SEK 150 million

Setterwalls advises USWE Sports in connection with a fully guaranteed rights issue

Setterwalls advises Amniotics in connection with public takeover bid

Setterwalls has advised Asgard Therapeutics AB in connection with a EUR 30 million Series A financing

Setterwalls advises Nordic Waterproofing in connection with the public takeover bid from Kingspan

Setterwalls has advised TrusTrace in connection with a financing of USD 24 million

Setterwalls has advised Crunchfish in connection with rights issue

Setterwalls has assisted Better Collective in connection with cross-listing on Nasdaq Copenhagen

Setterwalls has assisted SynAct Pharma in connection with a private placement of SEK 60.5 million

Setterwalls has advised Alligator Bioscience in connection with rights issue of approximately SEK 181 million

Setterwalls has advised Iconovo in connection with private placement

Setterwalls has assisted SynAct Pharma in connection with the acquisition of TXP Pharma and private placement

Setterwalls has advised Guard Therapeutics in connection with private placement of approximately SEK 120 million

Setterwalls has advised InCoax Networks in connection with rights issue and over-allotment

Setterwalls has advised Qlife Holding in connection with rights issue

Setterwalls has advised SynAct Pharma AB in connection with listing on Nasdaq Stockholm

Setterwalls has advised Respiratorius and Arcede Pharma in connection with a rights issue and Lex Asea distribution of shares

Setterwalls has advised inriver AB in connection with a major growth investment from Thomas H. Lee Partners (THL)

Setterwalls has advised SynAct Pharma AB in connection with a fully guaranteed rights issue of approximately SEK 150 million

Setterwalls has advised Alligator Bioscience in connection with rights issue of approximately SEK 257 million

Setterwalls has advised Guard Therapeutics in connection with private placement and rights issue of in total approximately SEK 182 million

Setterwalls has advised Resurs Holding and Solid Försäkring in connection with the Lex Asea distribution of shares and admission to trading on Nasdaq Stockholm

Setterwalls has advised Crunchfish in connection with over-subscribed rights issue

Setterwalls has assisted 2150 and ETF Partners in connection with investment in Normative

Setterwalls has advised Aptahem in connection with rights issue

Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market

Setterwalls advises Linkfire A/S in connection with listing on Nasdaq First North Premier Growth Market

Setterwalls advises USWE Sports AB in connection with listing on Nasdaq First North Growth Market

Setterwalls assists Better Collective in connection with private placement of SEK 1.5 billion

Setterwalls advises Qlife Holding in connection with SEK 90 million private placement

Setterwalls has advised WntResearch in connection with rights issue

Setterwalls advises Ascelia Pharma in connection with SEK 200 million private placement

Setterwalls has advised SynAct Pharma in connection with SEK 80 million private placement

Setterwalls has advised Alligator Bioscience in connection with over-subscribed rights issue

Setterwalls has assisted inRiver in connection with the acquisition of Detail Online

Setterwalls has assisted Polygiene in connection with private placement and the acquisition of Addmaster

Setterwalls has advised Curando Nordic AB in connection with a rights issue

Setterwalls advised Thunderful Group AB in connection with the listing on Nasdaq First North Premier Growth Market

Setterwalls has advised Idogen in connection with rights issue of units

Setterwalls advises Boozt in connection with cross-listing on Nasdaq Copenhagen and offering of DKK 602 million

Setterwalls advises inRiver in connection with private placement of approximately SEK 285 million

Setterwalls has advised Aptahem in connection with over-subscribed rights issue

Setterwalls advised Alelion Energy Systems AB in connection with oversubscribed rights issue

Setterwalls has assisted Delvator’s owner in connection with the sale to Sørenco

Setterwalls has advised Guard Therapeutics in connection with rights issue and over-allotment

Setterwalls advises the majority shareholders in connection with sale of shares in Better Collective

Setterwalls has advised InCoax Networks AB in connection with an oversubscribed rights issue

Setterwalls advises Saniona in connection with directed issue of approximately SEK 567 million

Setterwalls has advised Advenica in connection with a substantially oversubscribed rights issue

Setterwalls advises Ascelia Pharma in connection with SEK 98.7 million private placement

Setterwalls has advised Safeture in connection with oversubscribed rights issue

Setterwalls has advised BONESUPPORT in connection with SEK 378 million private placement

Setterwalls has advised WntResearch in connection with oversubscribed rights issue

Setterwalls advises Qlife Holding AB in connection with the listing on Nasdaq First North Growth Market

Setterwalls has advised the main owners in connection with the sales of Inyett to Visma

Setterwalls advises Better Collective in connection with SEK 312 million private placement

Setterwalls has advised RhoVac in connection with a rights issue of approximately SEK 180.9 million

Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm

Setterwalls has advised EQL Pharma in connection with oversubscribed rights issue

Setterwalls has assisted Galecto Biotech in connection with the closing of a EUR 79 million Series C financing

Setterwalls advises Freespee AB in connection with Verdane’s investment in the company.

Setterwalls advises Better Collective in connection with listing on Nasdaq Stockholm

Setterwalls advised the sellers in connection with Zmarta Group’s acquisition of Elskling, Sweden’s leading online comparison platform for electricity

Setterwalls assists BONESUPPORT in connection with listing on Nasdaq Stockholm

Setterwalls assists Alligator Bioscience AB in connection with listing on Nasdaq Stockholm

Setterwalls Assists Mapillary AB in $8 Million series a round led by Atomico

Setterwalls assist in connection with the Private Placement in Nexam Chemical Holding AB (publ

Setterwalls has assisted Enzymatica AB (publ) in the acquisition of the Icelandic company Zymetech

Setterwalls assisted KLS Ugglarps in the acquisition of the majority shares in Dalsjöfors Kött

Setterwalls assist Allligator Bioscience in transaction with Johnson & Johnson

Setterwalls has assisted Arise AB (publ) in the sale of the wind farm Mombyåsen to Allianz Capital Partners

Setterwalls represents Boozt in connection with SEK 250 million fundraising

Setterwalls assists Mapillary AB in investment round led by Sequoia Capital

Setterwalls assists LIDDS in connection with fundraising and listing on NASDAQ OMX First North

Setterwalls acted as legal advisors in connection with Private Placement in Nexam Chemical Holding AB

Setterwalls assists in connection with a MSEK 120 investment round in Bonesupport

Midsona Group AB chooses Setterwalls

Setterwalls has assisted FSG with an investment in Evam

Läs nyhet

The Listing Act – The European Union’s new legislative package aimed to facilitate for companies listing shares and companies acting in a listed environment

Läs nyhet

Reduced possibilities for reverse share splits due to changes in Euroclear’s rulebook

Läs nyhet

The Swedish Financial Supervisory Authority (Sw. Finansinspektionen) announces decisions affecting the use of share loans in connection with private placements

Läs nyhet

The Listing Act – The European Commission’s proposed initiative to facilitate for companies listing shares and companies acting in a listed environment

Läs nyhet

Certain features of Swedish company law to observe when negotiating representations and warranties in connection with fundraising

Läs nyhet